Show simple item record

dc.contributor.authorBachelder, Robin E.
dc.contributor.authorYoon, Sang-oh
dc.contributor.authorFranci, Clara
dc.contributor.authorde Herreros, Antonio Garcia
dc.contributor.authorMercurio, Arthur M.
dc.date2022-08-11T08:08:02.000
dc.date.accessioned2022-08-23T15:39:50Z
dc.date.available2022-08-23T15:39:50Z
dc.date.issued2005-01-06
dc.date.submitted2010-11-07
dc.identifier.citationJ Cell Biol. 2005 Jan 3;168(1):29-33. <a href="http://dx.doi.org/10.1083/jcb.200409067">Link to article on publisher's site</a>
dc.identifier.issn0021-9525 (Linking)
dc.identifier.doi10.1083/jcb.200409067
dc.identifier.pmid15631989
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26264
dc.description.abstractWe report that the activity of glycogen synthase kinase-3 (GSK-3) is necessary for the maintenance of the epithelial architecture. Pharmacological inhibition of its activity or reducing its expression using small interfering RNAs in normal breast and skin epithelial cells results in a reduction of E-cadherin expression and a more mesenchymal morphology, both of which are features associated with an epithelial-mesenchymal transition (EMT). Importantly, GSK-3 inhibition also stimulates the transcription of Snail, a repressor of E-cadherin and an inducer of the EMT. We identify NFkappaB as a transcription factor inhibited by GSK-3 in epithelial cells that is relevant for Snail expression. These findings indicate that epithelial cells must sustain activation of a specific kinase to impede a mesenchymal transition.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=15631989&dopt=Abstract">Link to Article in PubMed</a>
dc.subjectBreast
dc.subjectCadherins
dc.subjectCell Line
dc.subjectDNA-Binding Proteins
dc.subjectEpithelial Cells
dc.subjectFemale
dc.subject*Gene Expression Regulation
dc.subjectGenes, Reporter
dc.subjectGlycogen Synthase Kinase 3
dc.subjectHumans
dc.subject*Mesoderm
dc.subjectNF-kappa B
dc.subjectPhenotype
dc.subjectRNA, Small Interfering
dc.subjectRecombinant Fusion Proteins
dc.subjectTranscription Factors
dc.subject*Transcription, Genetic
dc.subjectCancer Biology
dc.subjectNeoplasms
dc.titleGlycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition
dc.typeJournal Article
dc.source.journaltitleThe Journal of cell biology
dc.source.volume168
dc.source.issue1
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1178&amp;context=cancerbiology_pp&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/cancerbiology_pp/178
dc.identifier.contextkey1633404
refterms.dateFOA2022-08-23T15:39:50Z
html.description.abstract<p>We report that the activity of glycogen synthase kinase-3 (GSK-3) is necessary for the maintenance of the epithelial architecture. Pharmacological inhibition of its activity or reducing its expression using small interfering RNAs in normal breast and skin epithelial cells results in a reduction of E-cadherin expression and a more mesenchymal morphology, both of which are features associated with an epithelial-mesenchymal transition (EMT). Importantly, GSK-3 inhibition also stimulates the transcription of Snail, a repressor of E-cadherin and an inducer of the EMT. We identify NFkappaB as a transcription factor inhibited by GSK-3 in epithelial cells that is relevant for Snail expression. These findings indicate that epithelial cells must sustain activation of a specific kinase to impede a mesenchymal transition.</p>
dc.identifier.submissionpathcancerbiology_pp/178
dc.contributor.departmentDepartment of Cancer Biology
dc.source.pages29-33


Files in this item

Thumbnail
Name:
JournalCellBiology_Glycogen_sy ...
Size:
1.063Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record